The Efficacy and Risk Profile of c-Met inhibitors in Non-small Cell Lung Cancer: a Meta-analysis - Ye, Sa; Li, Jiuke; Hao, Ke; Yan, Jianping; Zhou, Hongbin (Scientific reports, 2016)
Keywords: 692/4028/67/1059/602; 692/4028/67/1612/1350; Adenocarcinoma; Antineoplastic Agents - adverse effects; Antineoplastic Agents - pharmacology; Carcinoma, Non-Small-Cell Lung - drug therapy; Carcinoma, Non-Small-Cell Lung - mortality; Carcinoma, Non-Small-Cell Lung - pathology; Disease control; Disease-Free Survival; Drugs; Humanities and Social Sciences; Humans; Inhibitors; Lung cancer; Lung Neoplasms - drug therapy; Lung Neoplasms - mortality; Lung Neoplasms - pathology; Meta-analysis; Metastases; multidisciplinary; Non-small cell lung carcinoma; Protein Kinase Inhibitors - adverse effects; Protein Kinase Inhibitors - pharmacology; Proto-Oncogene Proteins c-met - antagonists & inhibitors; Science; Survival; Survival Analysis